[February 19, 2018] |
|
Global Over-the-Counter (OTC) Drug Markets 2017-2023: Johnson & Johnson Maintains a Top Market Position Despite Growing Consolidation and Competition - ResearchAndMarkets.com
The "Global
Over-the-Counter (OTC) Drug Markets" report has been added to ResearchAndMarkets.com's
offering.
The report includes discussions of conditions often treated with OTC
medicines, health statistics related to the industry, global
populations, aging populations, populations by region and issues
affecting the market as a whole. Information is presented as a global
overview, with special emphasis on primary markets such as the United
States, Japan, China, Germany, and other key markets. The market
segments provide an overview of demographics, market estimates and
market forecasts.
This Study Divides and Discusses OTC Product Markets in Five
General Segments:
-
OTC Central Nervous System Agents (Analgesics, Anti-Inflammatories,
and Other Central Nervous System Agents)
-
OTC Dermatological Agents (Acne Treatments,
Antifungals/Antiinfectives, Hair Growth Remedies, Others)
-
OTC Gastrointestinal System Agents (Laxatives, Antacids,
Antidiarrheals, H2 Antagonists, Proton Pump Inhibitors)
-
OTC Respiratory System Agents (Antihistamines, Decongestants, Cough
Preparations, Other Respiratory Agents)
-
OTC Agents - Various Therapeutic Classifications (Smoking Cessation
Market, Contraceptive Drugs, Weight Management Drugs [OTC drugs, not
dietary supplements], Overactive Bladder Tretments)
Key Topics Covered:
1. Executive Summary
2. Introduction
3. Over The Counter Central Nervous System Agents
4. Over-The-Counter Dermatological Agents
5. Over-The-Counter Gastrointestinal System Agents
6. Over-The-Counter Respiratory System Agents
7. Over-The-Counter Agents-Various Therapeutic Classifications
8. OTC Drug Markets In Asia Pacific
9. OTC Drug Markets In Europe
10. OTC Drug Markets In Latin America
11. OTC Drug Markets In Middle East & Africa
12. OTC Drug Markets In North America
13. Leading OTC Drug Manufacturers
-
Competitor Analysis
-
GlaxoSmithKline Grabs Top Market Position
-
Bayer Holds Second in a Highly Competitive Market
-
Sanofi Climbs to Third in Market with Recent Acquisition
-
Johnson & Johnson Maintains a Top Market Position in OTC Drugs
despite Growing Consolidation and Competition
-
Reckitt Benckiser Maintains Consistent Sales
-
Perrigo Is the Leading Off-Brand OTC Drug Company
-
Pfizer Is Steadfast
-
Taisho Pharmaceutical: Japan's Leading OTC Drug Supplier
-
Procter & Gamble Shows Slow, Steady Growth
-
A Decade of Agreements, Mergers and Acquisitions Shaping the OTC Drug
Market
-
Sanofi and Boehringer Ingelheim
-
GlaxoSmithKline and Novartis AG
-
Bayer AG and Merck & Co.
-
Prestige Brands and Insight Pharmaceuticals
-
Perrigo Company Acquisitions
-
Procter & Gamble and Teva Pharmaceutical Industries
-
Sanofi and Chattem Consumer
-
Wyeth and Pfizer
-
Reckitt Benckiser and Adams Respiratory Therapeutics
-
Leading Corporate Profiles
-
Bayer AG
-
GlaxoSmithKline plc
-
Johnson & Johnson
-
Mylan N.V.
-
Perrigo Company plc
-
Pfizer, Inc.
-
Procter & Gamble Company
-
Reckitt Benckiser Group Plc
-
Sanofi
-
Taisho Pharmaceutical Holding Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/5d9rxg/global?w=4
View source version on businesswire.com: http://www.businesswire.com/news/home/20180219005314/en/
[ Back To TMCnet.com's Homepage ]
|